Designated organic active ingredient containing (doai) > Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso doai > Benzene ring containing > Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/649
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso doai > Benzene ring containing > Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain
Description: Subject matter wherein an amino nitrogen is indirectly bonded to an aryl ring system through a single carbon or through an acyclic chain.

Sub-classes under this class:

Class Number	Class Name	Patents
514/651	Ether oxygen is part of the chain	370
514/653	Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)	439
514/655	The aryl ring or aryl ring system and amino nitrogen are bonded directly to the same acylic carbon, which carbon additionally has only hydrogen or acyclic hydrocarbyl substituents bonded directly thereto	213
514/650	The aryl ring or aryl ring system is bonded directly to another ring or ring system	140
514/654	The chain consists of two or more carbons which are unsubtituted or have acyclic hydrocarbyl substituents only	417

Patents under this class:

1 2 3 4 5 6 7 8 9 10

Patent Number	Title Of Patent	Date Issued
5556886	HIV-inhibiting benzeneacetamide derivatives	Sep. 17, 1996
5556857	Disturbance-of-consciousness improving agent	Sep. 17, 1996
5554656	Disinfectant concentrates and disinfectants on amine and alcohol base and their use	Sep. 10, 1996
5552162	Method for improvement of scar size and appearance	Sep. 3, 1996
5550107	Combination therapy for the treatment of estrogen-sensitive disease	Aug. 27, 1996
5547994	Method for treating asthma using optically pure R(-) albuterol	Aug. 20, 1996
5541231	Stabilized Pharmaceutical	Jul. 30, 1996
5534531	Compounds	Jul. 9, 1996
5530028	Insecticidal N'-substituted-N,N'-diacylhydrazines	Jun. 25, 1996
5525631	Compositions of the ethyl ester of L-DOPA	Jun. 11, 1996
5525633	Triaryl-ethylene derivatives	Jun. 11, 1996
5521220	Acyclic ethylenediamine derivatives	May. 28, 1996
5504115	Inhibitors of farnesyl protein transferase	Apr. 2, 1996
5480912	Method of treating HIV-1 with .alpha.-substituted benzenemethanamine derivatives	Jan. 2, 1996
5462965	Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases	Oct. 31, 1995
5459140	Combination preparation based on dipivalylepinephrine (DPE) for reducing intraocular pressure	Oct. 17, 1995
5455276	Method for treating depression	Oct. 3, 1995
5455266	Enhanced chemotherapeutic compositions against microbial infections in fish, the preparation and use thereof	Oct. 3, 1995
5455271	Tight-binding inhibitors of leukotriene A.sub.4 hydrolase	Oct. 3, 1995
5446068	1-phenyl-3-phenyl-2-propyne-1-ones as calcium uptake inhibitors	Aug. 29, 1995
5446027	Amide derivative and external skin care preparation containing the same	Aug. 29, 1995
5446069	Benzoalkano compounds and their use for tracting hyperproliferative diseases	Aug. 29, 1995
5438056	Heterocyclic oxime carbamates	Aug. 1, 1995
5436243	Aminoanthraquinone derivatives to combat multidrug resistance	Jul. 25, 1995
5417987	Method for controlling bivalves such as zebra mussels	May. 23, 1995
5407961	.alpha.-substituted benzenemethanamine derivatives and pharmaceutical use	Apr. 18, 1995
5395853	Anti-atherosclerotic diaryl compounds	Mar. 7, 1995
5395611	Phenolic amine depigmenting and antimelanoma agents	Mar. 7, 1995
5389686	Analgesic properties of fedotozine	Feb. 14, 1995
5362755	Method for treating asthma using optically pure (R)-albuterol	Nov. 8, 1994
5362747	2-nitroaryl and 2-cyanoaryl compounds as regulators of nitric oxide synthase	Nov. 8, 1994
5360820	Medical use for tachykinin antagonists	Nov. 1, 1994
5358970	Pharmaceutical composition containing bupropion hydrochloride and a stabilizer	Oct. 25, 1994
5356934	Selected serotonin subtype receptor agonist to treat sleep apnea	Oct. 18, 1994
5354780	Intraoral dosing method of administering (+)-.alpha.-4-(dimethylamino)-3-methyl-1,2-diphenyl-2-butanolpropionate	Oct. 11, 1994
5352705	Inhibitors of farnesyl protein transferase	Oct. 4, 1994
5340826	Pharmaceutical agents for treatment of urinary incontinence	Aug. 23, 1994
5331007	Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties	Jul. 19, 1994
5322859	Antiglaucoma drug composition and method	Jun. 21, 1994
5290814	Anti-atherosclerotic diaryl compounds	Mar. 1, 1994
5288742	.alpha.,.alpha. dialkylbenzyl derivatives	Feb. 22, 1994
5280045	4(3,5-bis(1,1-dimethylethyl-4-hydroxyphenyl)-4-oxobutanamide compound useful as an anti-inflammatory agent	Jan. 18, 1994
5274002	Trisubstituted phenyl analogs having activity for congestive heart failure	Dec. 28, 1993
5268385	Method for treating schizophrenia	Dec. 7, 1993
5260333	Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions	Nov. 9, 1993
5256698	Treatment of psychosis using cyclohexyl-phenyl-lower alkyl amine derivatives	Oct. 26, 1993
5240707	Alpha-mannosidase and fucosidase inhibitors	Aug. 31, 1993
5236951	Pharmaceutical compositions for the treatment of ocular disorders	Aug. 17, 1993
5225446	Use of 1-deprenyl for retention of specific physiological functions	Jul. 6, 1993
5225436	Aryl substituted naphthalene derivatives	Jul. 6, 1993